Sea Crest Wealth Management, LLC Co Diagnostics, Inc. Transaction History
Sea Crest Wealth Management, LLC
- $916 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding CODX
# of Institutions
45Shares Held
5.59MCall Options Held
67.5KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA1.78MShares$675,7090.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$449,0200.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny556KShares$211,1360.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$190,7690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$131,2940.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $12.8M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...